ইউরোপীয় ইউনিয়ন - ডেনিশ - EMA (European Medicines Agency)

eisai gmbh - perampanel - epilepsier, delvis - antiepileptika, , andre antiepileptika - fycompa er indiceret til supplerende behandling af partielle anfald med eller uden sekundært generaliserede anfald hos voksne og unge patienter fra 12 år med epilepsi. fycompa er angivet for den adjuverende behandling af primær generaliseret tonisk-kloniske anfald hos voksne og unge patienter 12 år med idiopatisk generaliseret epilepsi.

ইউরোপীয় ইউনিয়ন - ডেনিশ - EMA (European Medicines Agency)

midas pharma gmbh - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; diabetes complications - oftalmologiske - ranivisio is indicated in adults for:• the treatment of neovascular (wet) age-related macular degeneration (amd)• the treatment of visual impairment due to diabetic macular oedema (dme)• the treatment of proliferative diabetic retinopathy (pdr)• the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)• the treatment of visual impairment due to choroidal neovascularisation (cnv).

ইউরোপীয় ইউনিয়ন - ডেনিশ - EMA (European Medicines Agency)

eisai gmbh - lenvatinibmesilat - carcinom, nyrecelle - antineoplastiske midler - kisplyx is indicated for the treatment of adults with advanced renal cell carcinoma (rcc):in combination with pembrolizumab, as first-line treatment (see section 5. in combination with everolimus, following one prior vascular endothelial growth factor (vegf)-targeted therapy.

ইউরোপীয় ইউনিয়ন - ডেনিশ - EMA (European Medicines Agency)

galderma international - brimonidintartrat - hudsygdomme - andre dermatologiske præparater - mirvaso er indiceret til symptomatisk behandling af rosace ansigts erytem hos voksne patienter.

ডেনমার্ক - ডেনিশ - Lægemiddelstyrelsen (Danish Medicines Agency)

europharma.dk aps - methylphenidathydrochlorid - kapsler med modificeret udløsning, hårde - 10 mg

ডেনমার্ক - ডেনিশ - Lægemiddelstyrelsen (Danish Medicines Agency)

europharma.dk aps - methylphenidathydrochlorid - kapsler med modificeret udløsning, hårde - 20 mg

ডেনমার্ক - ডেনিশ - Lægemiddelstyrelsen (Danish Medicines Agency)

europharma.dk aps - methylphenidathydrochlorid - kapsler med modificeret udløsning, hårde - 30 mg

ডেনমার্ক - ডেনিশ - Lægemiddelstyrelsen (Danish Medicines Agency)

europharma.dk aps - methylphenidathydrochlorid - kapsler med modificeret udløsning, hårde - 40 mg

ইউরোপীয় ইউনিয়ন - ডেনিশ - EMA (European Medicines Agency)

otsuka novel products gmbh - delamanid - tuberkulose, multidrugt-resistent - antimyco-bakterielle midler - deltyba is indicated for use as part of an appropriate combination regimen for pulmonary multi-drug resistant tuberculosis (mdr-tb) in adults, adolescents, children and infants with a body weight of at least 10 kg when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability (see sections 4. 2, 4. 4 og 5. det bør overvejes at officielle vejledning om hensigtsmæssig brug af antibakterielle midler..

ইউরোপীয় ইউনিয়ন - ডেনিশ - EMA (European Medicines Agency)

biogen netherlands b.v. - nusinersen natrium - muskelatrofi, spinal - andre narkotika stoffer - spinraza er indiceret til behandling af 5q spinal muskelatrofi.